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1 Introduction
The mother, placenta and the fetus are
functionally and anatomically integrated but
the interplay between the parts of this feto-
maternal unit is difficult to study. In prenatal
pharmacology, toxicology, reproductive en-
docrinology and in nutritional research the
events in and the interplay between the tissues
are of particular interest to study. A non-
invasive technique which gives sequential in-
formation on the transfer of substances across
the placenta is therefore a great value.
Positron emission tomography (PET) is a new
technique which has been introduced during
the last few years for in vito studies of phar-
macological, physiological and biochemical
processes in the living body. We have employed
and introduced the PET technique in ex-
perimental perinatal medicine.
Our studies so far have been performed in the
feto-maternal unit of Rhesus monkeys and
focused on two important problems:
the kinetics of placental transfer and protein
incorporation of the amino acid nC-meth-
ionine,
the uptake and fetal kinetics of morphine and
heroin which are sometimes abused by pregnant
women.
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Particular emphasis is given to the me-
thodological aspects of the technique while the
original results are presented elsewhere in detail
[2,12]. Advantages and shortcomings of the
PET technique will also be discussed, as well
as the application of the method to phar-
macokinetic studies of drugs and nutritients in
the mother and fetus.
2 Positron emission tomography
A positron emission tomographic experiment
comprises three steps: production of ra-
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dionucleides, synthesis of "C-labelled ra- to the Rhesus monkey the samples were filtered
diotracer and investigation by positron emis- through 0.22 μπι membrane filters. The dose of
sion tomography. Most positron emitters have radiolabelled drug varied between 19—93 MBq
a rapid physical decay. Thus, the half-life of for "C-morphine and "C-heroin and 110-370
nC is only 20.4 minutes. MBq for "C-methionine. In some experiments
_. , r 11^ j *ι_ the radiolabelled dose was given together withThe decay of «C produces a positron, the an-
 & dose of ^  unlabdled analogue.
tiparticle of an electron. The positron is ther-
malized within a mm from the spot of decay in In the organic chemical preparation of the ra-
the tissue. The positron mass and an electron diolabelled tracers the time factor is as import-
mass are annihilated forming two antiparallel ant as the reaction yield. This is due to the
photons which are recorded by external de- rapid decay of J1C and therefore a minimum of
tectors. The data collected are utilized for re- time should elapse from the production of
construction of images, representing the ra- nCO2 to the administration of the radiolabelled
dionucleide distribution in transaxial slices of compound. The time used including organic
the body by use of standard computerized re- synthesis, purification by liquid chro-
construction principles. The three steps are de- matography and sterilization of the product did
scribed in more detail below. never exceed 60 minutes.
2.1 Radionucleide production 2.3 Animals
The production of radionucleides was per- Healthy well-nourished pregnant Rhesus mon-
formed at the Tandem Laboratory, University keys (Macaca mulatta) from the Primate Lab-
of Uppsala. 1JC was produced by bombardment oratory of Reproductive Research in Uppsala
of nitrogen gas with protons (HMeV, 15 μΑ). were used in the study. The age of the animals
In this method the nascent UC atoms react with ranged between 7 and 15 years, and their weight
trace amounts of oxygen present in the target was between 7.3 and 9.1 kg.
g a s forming mainly*1CO2. The11 CCh molecules „,
 x ... . 1 - 0
are trapped in a molecular sieve and tran- The f ?ntatl°^ *p at^?e time of experiment
sported to the laboratory for radiochemical w*f 20 * *J* ****'. Thf ^ T ^  *?'
synthesis esthetized with ketamme L M., and anesthesia
was maintained with repeated doses of 50 — 100
mg of ketamine. Two indwelling catheters were
2.2 Organic chemistry inserted in <^ηί leg veins one for ad-
ministration of the dose, the other for blood
The positron emitting radionucleide was used sampling. Catheters were also introduced into
in the organic synthesis of the desired ra- the urinary bladder and into the amniotic cav-
diolabelled compounds. The "COi from the ity, in the latter case by ultrasonic guidance,
accelerator was converted in a series of steps During the course of the studies a new tech-
to "C-methyl iodide [17, 18]. The "C-methyl nique for sampling of fetal blood was
iodide was used in methylation reactions of employed. The umbilical vein was punctured
homocysteine and the N-demethylated ana- by a thin needle under the guidance of ul-
logues of morphine and heroin, respectively, trasonography [13]. The monkey, was fixed in
Samples of the * ^ -methylated compound were a specially designed cradle in the positron emis-
isolated and analyzed with respect to their iden- sion tomograph so thai the fetal liver and one
tity and radiochemical purity. Radiochemical placenta were monitored simultaneously. All
purity was always above 98 per cent and the experiments were carried out after approval of
enantiomericpurityofLandDmethioninewas the Committee for Protection of Laboratory
above 99 per cent [2, 8]. Before administration Animals at the University of Uppsala.
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2.4 Positron emission tomography (PET)
Immediately after administration of the UC-
labelled compound imaging of the monkey
started. Two antiparallel photons, formed from
the annihilation are detected by two opposing
detectors fitted in a ring of detectors. A com-
puter controls the detector channels and cal-
culates the distribution of radioactivity in a
section of the object defined by the plane of
detector rings. The two basic ideas of positron
emission are: radionucleide distribution is de-
tected and quantified outside the body; and the
co-incidental detection in two opposing de-
tectors in the ring gives an accurate information
about the location of radioactivity [3].
A Scanditronix PC 384-3B positron emission
tomograph (AB Scanditronix, Uppsala, Swed-
en) was used. It is equipped with two rings of
detectors (96 in each ring) giving three sim-
ultaneous images with a slice thickness of
13 — 14 mm and a resolution of 8mm. Data
collection and analyses were performed as de-
scribed by ERIKSSON et al. [6]. A predetermined
program was used to record images for 12, 40
and 200 sec until the end of the investigation.
2.5 Evaluation of PET images
After image reconstruction it is possible to de-
lineate an organ or a part of an organ. The
computer quantitates the radioactivity cor-
rected for physical decay per unit of volume in
the regions of interest. As the administered
radioactivity and the body weight of the mon-
key are known, a measure denoted "uptake" is
calculated. This is defined as nCi per cm3 of
tissue, divided by the dose in nCi per gram of
body weight. An uptake value of 1.0 cor-
responds to an uptake as if the administered
radioactivity was homogeneously distributed in
the body of the monkey. The following regions
of interests were delineated: fetal liver, placenta,
maternal paraspinal muscle and aorta.
2.6 Pharmacokinetic analysis
Although PET by itself is non-invasive, ad-
ditional information may be obtained by com-
plimentary techniques. Samples of maternal ur-
ine, blood and amniotic fluid were thus col-
lected at regular intervals after dose and count-
ed for total radioactivity in a well counter (Nal
[Tl]). Radioactivity uptake, as defined above,
was measured in blood and amniotic fluid.
Blood samples were centrifuged and the 11C-
methionine derived radioactivity in the high
molecular fraction was measured after gel fil-
tration on Sephadex G25 with saline as mobile
phase [16].
In the case of morphine and heroin, the unla-
belled drug and the major plasma metabolite,
morphine-3-glucuronide (M3G), were analyzed
in plasma and amniotic fluid by means of high
performance liquid chromatography [19].
3 Possibilities and shortcomings of PET
3.1 Applications of PET
Positron emission tomography is a non-invasive
tracer technique which may be used to measure
the kinetics of physiological or biochemical
processes in animals or man. Pharmacological
studies are often aimed at the study of the
interaction in physiological mechanisms by
drugs or endogenous compounds. Thus, po-
sitron emission tomography provides unique
opportunities to study the in vivo kinetics of
drugs or the kinetics of incorporation of ra-
diolabelled endogenous compounds in bio-
chemical processes. As only trace amounts of
the compound are given, no pharmacological
effects are seen, and hence the kinetics can
be studied during undisturbed, physiological
conditions.
In man, PET has been used in order to measure
glucose utilization in the brain in mental dis-
orders, delineate and grade gliomas or pituitary
tumours after administration of different nC-
labelled amino acids [4, 11, 15] and it has been
used in studies of regional blood flow [1]. Stud-
ies have also been performed on the in-
tracerebral distribution of the dopamine an-
tagonist, HC-methyl-spiperone [20], which re-
flects the dopamine receptor population in the
J. Perinat. Med. 13 (1985)
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human brain. Thus, e. g. it has been shown that
the number of receptors decreases with age;
The human studies are often preceeded by ex-
periments in animals to evaluate the organ dis-
tribution of the radiotracer and to determine
its kinetics in the organ of interest.
Several pharmacokinetic studies have been per-
formed in animals, since the use of PET as an
autoradiographic in vivo technique will furnish
pharmacologists and pharmacokineticists with
data unavailable with other methods. Thus, the
uptake and kinetics of narcotic analgesics [8],
opioid peptides [9], and dopamine receptor an-
tagonists [20] have been studied in different
areas of the brain, as well as bromocriptine in
the pituitary [15]. The binding of nC-labelled
compounds in different areas of the brain en-
ables one to study the nature of reversible,
selective receptor binding and the mechanism
of receptor displacement. The irreversible bind-
ing of N-methyl-tetra-hydropyridin to melanin
containing cells in substantia nigra has thrown
light upon the etiology of Parkinsons disease
[14]. Distribution of opioids [7] and anesthetics
after epidural or intrathecal administration
may help to explain the mechanisms behind the
late respiratory depression observed in man
after spinal application of these drugs. Rapid
physiological processes may be described which
is of particular value in the studies of transfer of
compounds from mother to fetus in pregnancy.
Important studies on the extent and rate of
transfer of nutrients and drugs [2, 12] from the
mother to the fetus during pregnancy will be
reported below.
This review of some applications gives avidence
for the unique possibilities of PET to provide
data which cannot be obtained with other tech-
niques. Some shortcomings of the technique
will limit its use and create difficulties in the
interpretation of the results. These short-
comings may be circumvented by use of ad-
ditional methods.
3.2 Shortcomings of PET
The positron tomograph used has a spatial
resolution of 8 mm. This limits the possibilities
to study small organs and areas of interest in
fetuses. On the other hand, if the phar-
macokinetics of the fetus are studied, the whole
body kinetics can be integrated over time, as
well as the kinetics in a sufficiently large organ
such as the liver. The blood borne activity in
vividly perfused organs may interfere with the
evaluation of the radioactivity in the tissue.
Therefore correction for the radioactivity in
blood must be made. The blood volume can be
estimated after administration of 68Ga-EDTA
or 68GaCl2, which are distributed in-
travascularly to a high extent. It is thus possible
to study the tissue kinetics after correction for
the blood borne radioactivity.
In order to separate the ^C-derived activity
from the metabolites from that of the parent
drug, the PET may be complemented by ch-
romatographic methods [8, 16].
PET utilizes shortlived radio-isotopes as 15O,
13N and nC with a half-life of physical decay
of minutes. Studies lasting more than 2 hours
cannot be done. Autoradiography in small ani-
mals can complement the PET images [14]. The
uptake of * ^ -labelled tracer in different organs
may also be compared with the radioactivity
measured in a well counter from the whole
organ obtained after sacrifice of the animal.
The short physical half-life of 1!C is an ad-
vantage, since the radiation dose will be small.
Furthermore, repeated administration of HC-
labelled drug in the same animal in the same
experimental set up is possible. This means that
the animal may serve as its own control when
physiology is altered between experiments.
4 Interpretation of the results
4.1 Distribution and lipophilic property
The time for the drug to reach equilibrium in a
well-perfused organ is determined by the blood
flow and the distribution ratio of the drug be-
tween the tissue and blood. For the uptake in
brain, the lipophilic property of the drug is a
major determinant besides binding char-
acteristics in plasma and tissue. The lipophilic
J. Perinat. Med. 13 (1985)
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property of a drug may be expressed as the
distribution coefficient between octanol and
buffer (pH = 7.4 at 37 °C). For opioid drugs,
meperidine (pethidine) had the most rapid and
extensive uptake in the brain followed by her-
oin, codeine and morphine in order of de-
creasing lipophilic properties [8]. A higher than
expected uptake may indicate some kind of
active transport which has been shown for 1!C-
methionine in the brain [4], or it may indicate
irreversible binding to structures in the brain
as shown for N-phenyl-tetrahydropyridine [14].
The PET images from a nC-heroin experiment
are shown in Fig. 1, where the uptake of radio-
activity in placenta and fetal liver during the
first 27 minutes of the experiment is seen. The
uptake of heroin in the fetal liver was more
than three times higher than for the more hy-
drophilic morphine [12]. Maximum uptake was
also reached earlier with heroin.
The elimination rate of the * ^ -derived radio-
activity from the brain was in the same range
for heroin and morphine. This is probably due
to a rapid conversion of * ^ -heroin to J1C-
morphine. Therefore, after administration of
1
 ^ -heroin the late PET-images reflect the dis-
position of 1 ^ -morphine in the fetus.
HC-methionine rapidly reached the fetus, prob-
ably by a facilitated transport system. It was
also shown that the transport system was se-
lective for the L-enantiomer of methionine at
the expense of the D-form.
Uptah·
8 . 3
10 20
Tlmt (min) 30
4
17 27
Fig.l. PET-images of the distribution of nC in placenta (1) and fetal liver (2) 0.3 to 27 min after intravenous
administration of nC-heroin to a pregnant Rhesus monkey. To the upper right is shown the uptake in the fetal
liver (upper curve), and the placental uptake (lower curve), calculated from the regions of interest on the image.
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4.2 Plasma protein binding In the mother, morphine was rapidly converted
to M3G. The transfer of morphine to the fetus
An extensive plasma protein binding may limit
 was slow as was the fetal disposition of both
the uptake of the »C-labelled compound in
 morpbine and M3G [12]. At 100 minutes fol-
different organs. Endogenous compounds such
 lowing administration the morphine and M3G
as amino acids are also readily incorporated
 concentrations were higher in the fetus than in
in the high molecular fraction in plasma [2].
 ±e mothere This may reflect the slow transfer
However, the incorporation was selective and
 of hydrophilic metabolites across the placenta,
discriminative for the D-form of "Ometh-
ionine. Determination of lipophilic properties
and plasma protein binding of the 1 ^ -labelled
tracer is of great importance, not only in in- 4.4 Pharmacokinetic modelling
terpretation of the PET images, but also in _ - ,
 1 . - ,. . .
the elucidation of the mechanism of different Because of low resolution, the radioactivity
physiological processes. measured in the PET-images may derive from
adjacent organs, and incorporation of ^ -deri-
ved radioactivity in a physiological process may
be hidden in the unselective uptake of the !1C-
radiolabelled tracer. Therefore, pharma-
4.3 Pharmacokinetic analysis in plasma, urine cokinetic modelling is sometimes mandatory
and amniotic fluid for the interpretation of the results. Modelling
~
 r . , . « . , . . j u . ui j can be done in several ways. The easiest way isBefore equilibrium is attained between blood . j · · . ι i . - u - + /i_
, A . Ai 11 j ι · *· r Λ · J-.C to administer an analogue, which is not metab-and tissue, the blood kinetics of a drug is dif-
 r , , « '
 &
. ' . „ .r , _
ferent from that in the tissue. The early phase ^d or cannf *>e physiologically utilized. The
of drug disposition is prevailing during the PET-un^ of 1^  ai^<^ nay thus «midate
course of most PET studies. Therefore, it is of *e kme!*»_ of'he <?f™**a colnPound f
importance to distinguish the kinetics of the mteresf [5U]- In ?he <™^«™> receptor hgands
tracer in the tissue from that in blood. However, f/e οηί? bo,und non-selectively. By subtracting
PET studies of drugs with a high lipophilic thf radloa^vity in the cerebellum from that in
property and a high extent of non-selective other areas of the brain, the kinetics of the
binding in the brain tissue may well give results receptor blndmg can be descnbed ™'
which are similar to the blood kinetics of the For more sophisticated analysis a compartment
nC-tracer [10]. Blood kinetics cannot be studied model is required. Such a model for the feto-
by PET because of the radiation from tissues maternal unit is depicted in Fig. 2. By es-
and from drug metabolites. Radiochemical or timation of the value of the rate constants, the
chemical analyses of * ^ -labelled drug or unla- kinetics in maternal and fetal plasma of a drug
belled drug and metabolites in plasma may or an amino acid can be simulated. The results
solve this problem and are performed by means are given in Fig. 3 for morphine which was
of sensitive and selective Chromatographie given to a pregnant Rhesus monkey. A certain
methods [8,16]. resistance to transfer across the placenta was
Valuable pharmacokinetic data are obtained fs^fd· After ™rti<» of the measured values
from the urine, amniotic fluid and even fetal from the matemal ™d^ Pla*ma the different
blood [13]. After administration of "Conor- rate constants can be determined,
phine together with 14C-morphine and unla- By extending the compartment analysis to other
belled morphine-3-glucuroriide (M3G) to two compartments such as maternal urine and am-
pregnant Rhesus monkeys, the concentrations niotic fluid and inclusion of the data for the
of morphine and M3G were measured in plas- main metabolites of morphine, M3G, one may
ma, maternal urine, and amniotic fluid [12]. further strengthen the interpretation of the
One fetal blood sample was also available. transfer mechanisms in the feto-maternal unit.
J. Perinat. Med. 13 (1985)
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Fig. 2. Pharmacokinetic model for the disposition of
morphine in the blood of a Rhesus monkey mother and
fetus.
ο
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Fig. 3. Simulated concentrations of morphine in the
blood of mother (open triangles) and of the fetus (open
circles) together with measured values (closed symbols).
The pharmacokinetic compartment model depicted in
Fig. 2 was used with the following values of the rate
constants: kio = 0.12; kn = 0.70; k2i = 0.30; k34 = 0.70;
k43 = 0.30; ki3 = 0.003 and ksi = 0.0015 min-1. Si-
mulation was made with the pharmacokinetic computer
program DARE-P at UDAC at the University of Uppsa-
la.
The model can be employed for all kinds of
compounds and by inclusion of PET data a full
description of the kinetics is obtained.
5 Conclusions
The PET technique is based on several sciences
e. g. physics, radiobiology, organic chemical
synthesis, pharmacology, pharmacokinetics, ra-
diology and several clinical disciplines. The
number of people involved in a PET-ex-
periment is in the order of 4 — 8. The high
costs of the method may hamper its further
development in experimental pharmacology.
PET has many applications but one of its major
impacts has been in studies on the kinetics and
transfer mechanisms in the feto-maternal unit.
Because of its non-invasive character, the PET
methodology gives information which are un-
available by other techniques. Since studies are
performed in the Rhesus monkey the results
may be extrapolated to man. The placental
transfer mechanisms are studied by phar-
macokinetic modelling, which support the in-
terpretation of the results. The presented
method is of interest in studies of develop mental
pharmacology in the feto-placental unit and is
applicable to several types of compounds, in-
cluding nutrients and drugs ingested or abused
by the mother.
Summary
Positron emission tomography (PET) is a new tracer
technique by which short-lived radionucleides, such as
nC are used for labelling drugs, amino acids and other
compounds. The concentration in the various organs is
determined non-invasively after I.V. injection. Posi-
trons, emitted by nC attract an electron, and the two
masses are annihilated by emitting photons. These can
be registered by external detectors. Measurement of the
radioactivity per volume of tissue as a function of time
is accomplished by computerized processing of the data.
The PET technique may be used for studies of the
kinetics of the injected compound in different organs
of the body. However, PET registers only the total
radioactivity meaning that the measured * ^ -radio-
activity represents the sum of the parent compound and
the radiolabelled metabolites. Chemical and ra-
diochemical analyses in various body fluids may then
help to interpret the PET images.
The major use of PET has been in studies of metabolism
and receptor binding in the brain. The present paper is
a review of the PET technique as used in experimental
perinatal medicine.
We have employed PET in kinetic studies of methionine
in the fetomaternal unit of Rhesus monkeys. After I. V.
injection of nC-L- or D-methionine, the distribution of
radioactivity in maternal muscles, placenta and fetal
liver were registered. There was a rapid transport of nC-
activity to the fetal compartments after administration
of the two enantiomers. By analyses of the radioactivity
in maternal plasma after gel separation, it was found
that only the L-form was used in the protein synthesis.
PET is thus suitable for studies of stereospecific kinetics
and metabolism of amino acids in the feto-maternal
unit.
In another project, the kinetics of the opiates 1 ^ -mor-
phine and 1!C-heroin were studied in pregnant Rhesus
J. Perinat. Med. 13 (1985)
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monkeys. The opiates were rapidly metabolized why the
PET images had to be complemented by analyses of
samples from maternal blood, urine, and amniotic fluid.
Fetal blood was also obtained through puncture of the
umbilical vein.
Both i ^ -morphine and * ^ -heroin were rapidly tran-
sported to the fetus. The heroin derived "C-activity in
the fetal liver was almost three times higher than that
of ^-morphine, which may reflect the difference in
lipophilic property between these drugs. The con-
centration of morphine in fetal blood was twice that in
maternal blood after 100 min.
Data from PET studies of morphine in the feto-maternal
unit were used in the simulation of pharmacokinetic
compartment models/ Such simulation may aid in the
'interpretation of results from PET studies, and eliminate
the need for additional analyses of body fluids. Thus,
the non-invasive character of PET implies a great po-
tential for studies in experimental perinatal medicine.
Keywords: Carbon-11, methionine, opiates, placental transfer, positron emission tomography, pregnancy, Rhesus
monkeys.
Zusammenfassung
Positron-Emissionstomographie in der experimentellen
. Perinatologie
Die Positron-Emissionstomographie (PET) ist eine neue
Technik, die auf der Markierung von Medikamenten,
Aminosäuren und anderen Verbindungen mit kurzlebi-
gen Nukliden wie z. B. nC basiert. Nach i. v.-Injektionen
kann die Konzentrationsbestimmung in den verschiede-
nen Organen nicht-invasiv erfolgen. Die durch das UC
emittierten Positronen ziehen ein Elektron an und unter
Aussendung von Photonen löschen sich die beiden Mas-
sen aus. Dieser Vorgang kann durch externe Detektoren
registriert werden. Die Messung der Radioaktivität, die
pro Volumeneinheit in einem Gewebe in Abhängigkeit
von der Zeit auftritt, erfolgt über eine computergesteuer-
te Datenerfassung. Über die PET läßt sich die Kinetik
der injizierten Verbindungen in den verschiedenen Kör-
perorganen verfolgen. Jedoch erfaßt die PET die Gesam-
taktivität, d. h. sowohl die Aktivität der Ausgangsver-
bindung wie auch die der radioaktiven Metabolite. Che-
mische und radiochemische Analysen der verschiedenen
Körperflüssigkeiten können dann die Interpretation der
PET-Bilder erleichtern.
Bisher wurde die PET bei Untersuchungen von metaboli-
schen Prozessen und Rezeptoren im Gehirn eingesetzt.
Die vorliegende Arbeit berichtet über den Einsatz der
PET in der experimentellen Perinatalmedizin.
Wir haben mit der PET die Kinetik des Methionins in
der fetomaternalen Einheit bei Rhesusaffen untersucht.
Nach i. v.-Injektion von * ^ -markiertem L- oder D-
Methionin wurde die Verteilung der Radioaktivität im
mütterlichen Muskelgewebe, in der Plazenta und in der
fetalen Leber registriert. Dabei wurde ein rascher Trans-
port der beiden Verbindungen zu den fetalen Komparti-
menten beobachtet. Die Untersuchung des maternalen
Plasmas mit Hilfe der Gelelektrophorese zeigte, daß
ausschließlich die L-Form bei der Proteinbiosynthese
eingebaut wird. Die PET ist somit auch zur Untersu-
chung der stereospezifischen Kinetik und des Metabolis-
mus von Aminosäuren in der fetomaternalen Einheit
geeignet.
In einer anderen Studie wurde die Kinetik der Opiate
nC-Morphin und nC-Heroin bei schwangeren Rhesu-
saffen untersucht. Die Opiate wurden rasch metaboli-
siert; die PET-Bilder wurden durch Analysen von müt-
terlichen Blut- und Urinproben sowie Fruchtwasserpro-
ben ergänzt. Zur Gewinnung von fetalem Blut wurde
die Nabelvene punktiert.
Sowohl nC-Morphin wie auch nC-Heroin wurden rasch
zum Feten transportiert. In der fetalen Leber war die
vom Heroin abstammende Radioaktivität dreimal höher
als die vom nC-Morphin, was die unterschiedliche Fett-
löslichkeit dieser beiden Verbindungen widerspiegelt.
Nach 100 Minuten war die Konzentration des Morphins
im fetalen Blut doppelt so hoch wie im mütterlichen
Serum.
Auf der Basis der PET-Studien mit Morphin in der
fetomaternalen Einheit wurde ein pharmakokinetisches
Modell für Untersuchungen in verschiedenen Komparti-
menten simuliert. Eine solche Simulation erleichtert die
Interpretation von PET-Ergebnissen; auf eine zusätz-
liche Analyse von Körperflüssigkeiten kann dann ver-
zichtet werden. Aus dem nicht-invasiven Charakter der
PET ergibt sich ein großes Potential für experimentelle
\Studien in der Perinatalmedizin.
Schlüsselwörter: nC, Methionin, Opiate, plazentarer Transfer, Positron-Emissionstomographie, Rhesusaffen,
Schwangerschaft.
Resume
Tomographie ä emission de positron en perinatalogie
experimental
La tomographie ä emission de positron (T. E. P.) est une
nouvelle technique de marquage au cours de laquelle on
utilise des radionucleides ä vie courte, tels que le 11 C,
ppur marquer des medicaments, des acides amines et
äütres composes. On determine de fagon non invasive
la concentration dans les divers organes apres injection
J. Perinat. Med. 13 (1985)
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I. V. Lcs positrons cmis par le 11 C attirent un electron
et les deux masses sont annihilces en emettant des pho-
tons. Ces photons peuvcnt etre enregistres par des detec-
teurs externes. La mesure de la radioactivito par volume
de tissu en fonction du temps est realisee par traitement
informatique des donnees. La technique T. E. P. peut
ctre utilisee pour ctudier la cinetique des composos injec-
tes dans les difforents organes du corps. Toutefois, la
T. E. P. n'enregistre que la radioactivite totale ce qui
signifie que la radioactivito 11 C mcsurec reprosente la
somme des composos injectcs et des metabolites mar-
ques. Les analyses chimiques et radiochimiques des di-
vers fluides de Porganisme peuvent alors aider a inter-
preter les images T. E. P.
L'utilisation principalc de la T. E. P. a etc Potudc du
metabolisme et de la fixation sur les recepteurs au niveau
cerebral. Get article est une revue de techniques de
la T. E. P. dans son utilisation en modecine p6rinatalc
cxperimcntalc.
Nous avons employe la T. E. P. dans les etudes cinetiques
de la methionine dans Funite foeto-maternelle de singes
Rhesus. On a enregistre la distribution de la radioactivite
dans les muscles maternels, le placenta et le foie foetal
apres injection I. V. de 11 C. L. ou D. methionine. II y
a un transport rapide de Pactivite 11 C vers les comparti-
ments foetaux apres administration des deux enantio-
meres. En analysant la radioactivite sur gel, on a trouve
que seule la forme L est utilisee pour la synthese protei-
que. Ainsi, la T. E. P. est appropriee pour les etudes
des cinetiques stereo-spccifiques et du metabolisme des
acides amines dans Punite foeto-maternelle.
Dans un autre projet, les cinotiques des opiaces mor-
phine 11 C et heroine 11 C ont etc etudices chez des
guenons rhesus gravides. Les opiaces sont rapidement
motabolisos c'est pourquoi les images de T. E. P. doivent
etre completees par Panalyse d'echantillons de sang ma-
ternel, d'urine et de liquide amniotique, on a egalement
obtenu du sang foetal par ponction de la veine ombilicale.
La morphine 11 C et Pherome 11 C sont rapidement
transportos vers le foetus. Uactivitc 11 C dans le foie
foetal, en provenance de Pherome est presque trois fois
plus 61evee que celle derivant de la 11 C morphine, ce
qui peut rcflcter la difference de lipophilie entrc ces
substances. Les concentrations de morphine dans le sang
foetal sont le double de celles du sang malernel au bout
de 100 minutes.
Les donnees tiroes des etudes avec T. E. P. de la morphi-
ne dans 1'unito foeto-maternelle ont etc utilisees pour la
simulation de modeles de compartiments pharmacocine-
tiques. De telles simulations peuvent aider Pinterpreta-
tion des rcsultats provenant des etudes de T. E. P. et
eliminer la necessite d'analyses complementaires des li-
quide de Porganisme. Ainsi, le caractere non invasif de
la T. E. R souligne son vaste potentiel pour les etudes
concernant la medecine perinatalc cxperimentale.
Mots-cles: Carbone 11, grossesse, methionine, opiaces, singes Rhesus, tomographie a emission de positrons,
träniert placentaire.
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